title: PBPK model of methotrexate in cerebrospinal fluid ventricles using a combined microdialysis and MRI acquisition.
abstract: The objective of the study was to evaluate the distribution of methotrexate (MTX) in cerebrospinal fluid (CSF) lateral ventricles and in cisterna magna after 3rd intraventricular CSF administration in a rabbit model. MTX or gadolinium chelate (Gd-DOTA) was administered in the 3rd ventricle with a local microdialysis to study the pharmacokinetics at the site of administration and with a simultaneous magnetic resonance imaging (MRI) acquisition in the 3rd ventricle, the lateral ventricles and in the cisterna magna. A specific CSF Physiologically Based Pharmacokinetic (PBPK) model was then extrapolated for MTX from Gd-DOTA data. The relative contribution of elimination and distribution processes to the overall disposition of MTX and Gd-DOTA in the 3rd ventricle was similar (i.e., around 60% for CLE and 40% for CLI) suggesting that Gd-DOTA was a suitable surrogate marker for MTX disposition in ventricular CSF. The PBPK predictions for MTX both in CSF of the 3rd ventricle and in plasma were in accordance with the in vivo results. The present study showed that the combination of local CSF microdialysis with MRI acquisition of the brain ventricles and a PBPK model could be a useful methodology to estimate the drug diffusion within CSF ventricles after direct brain CSF administration. Such a methodology would be of interest to clinicians for a rationale determination and optimization of drug dosing parameters in the treatment of leptomeningeal metastases.
authors.affiliation: Université de Rennes 1, Rennes, France; Laboratoire de Pharmacie Galénique, Biopharmacie et Pharmacie Clinique, IRSET U1085, Rennes, France.
authors.forename: Nolwenn
authors.initials: N
authors.lastname: Brandhonneur
authors.affiliation: Université de Rennes 1, Rennes, France; LTSI, INSERM, UMR 1099, Rennes, France.
authors.forename: Fanny
authors.initials: F
authors.lastname: Noury
authors.affiliation: Université de Rennes 1, Rennes, France; Laboratoire de Pharmacie Galénique, Biopharmacie et Pharmacie Clinique, IRSET U1085, Rennes, France.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Bruyère
authors.affiliation: Université de Rennes 1, Rennes, France; LTSI, INSERM, UMR 1099, Rennes, France; CRLCC, Centre Eugène Marquis, Rennes, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Saint-Jalmes
authors.affiliation: Université de Rennes 1, Rennes, France; Laboratoire de Pharmacie Galénique, Biopharmacie et Pharmacie Clinique, IRSET U1085, Rennes, France; Pôle Pharmacie, CHU de Rennes, France. Electronic address: pascal.le-corre@univ-rennes1.fr.
authors.forename: Pascal
authors.initials: P
authors.lastname: Le Corre
mesh_terms: D000818:Animals; D002552:Cerebral Ventricles / Q000378:metabolism*; D007276:Injections, Intraventricular; D008279:Magnetic Resonance Imaging; D008727:Methotrexate / Q000008:administration & dosage* / Q000097:blood / Q000134:cerebrospinal fluid / Q000493:pharmacokinetics; D017551:Microdialysis; D011817:Rabbits
chemical_list: D008727:Methotrexate
keywords: CSF ventricle administration; Gd-DOTA; MRI; Methotrexate; PBPK modeling